-
Je něco špatně v tomto záznamu ?
Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products
H. Jansová, J. Bureš, M. Macháček, P. Hašková, A. Jirkovská, J. Roh, Q. Wang, KJ. Franz, P. Kovaříková, T. Šimůnek,
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
- MeSH
- aldehydy farmakologie toxicita MeSH
- buněčné linie MeSH
- chelátory železa farmakologie toxicita MeSH
- hydrazony farmakologie toxicita MeSH
- krysa rodu rattus MeSH
- kyseliny boronové farmakologie toxicita MeSH
- kyseliny isonikotinové farmakologie toxicita MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- myoblasty srdeční účinky léků metabolismus MeSH
- oxidační stres účinky léků MeSH
- peroxid vodíku toxicita MeSH
- poločas MeSH
- reaktivní formy kyslíku metabolismus MeSH
- viabilita buněk účinky léků MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- železo metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Free cellular iron catalyzes the formation of toxic hydroxyl radicals and therefore chelation of iron could be a promising therapeutic approach in pathological states associated with oxidative stress. Salicylaldehyde isonicotinoyl hydrazone (SIH) is a strong intracellular iron chelator with well documented potential to protect against oxidative damage both in vitro and in vivo. Due to the short biological half-life of SIH and risk of toxicity due to iron depletion, boronate prochelator BSIH has been designed. BSIH cannot bind iron until it is activated by certain reactive oxygen species to active chelator SIH. The aim of this study was to examine the toxicity and cytoprotective potential of BSIH, SIH, and their decomposition products against hydrogen peroxide-induced injury of H9c2 cardiomyoblast cells. Using HPLC, we observed that salicylaldehyde was the main decomposition products of SIH and BSIH, although a small amount of salicylic acid was also detected. In the case of BSIH, the concentration of formed salicylaldehyde consistently exceeded that of SIH. Isoniazid and salicylic acid were not toxic nor did they provide any antioxidant protective effect in H9c2 cells. In contrast, salicylaldehyde was able to chelate intracellular iron and significantly preserve cellular viability and mitochondrial inner membrane potential induced by hydrogen peroxide. However it was consistently less effective than SIH. The inherent toxicities of salicylaldehyde and SIH were similar. Hence, although SIH - the active chelating agent formed following the BSIH activation - undergoes rapid hydrolysis, its principal decomposition product salicylaldehyde accounts markedly for both cytoprotective and toxic properties.
Department of Chemistry Duke University Durham NC 22708 USA
Faculty of Pharmacy Charles University Prague 500 05 Hradec Králové Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024087
- 003
- CZ-PrNML
- 005
- 20170829130059.0
- 007
- ta
- 008
- 170720s2016 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tox.2016.03.004 $2 doi
- 035 __
- $a (PubMed)27046792
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Jansová, Hana $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 245 10
- $a Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products / $c H. Jansová, J. Bureš, M. Macháček, P. Hašková, A. Jirkovská, J. Roh, Q. Wang, KJ. Franz, P. Kovaříková, T. Šimůnek,
- 520 9_
- $a Free cellular iron catalyzes the formation of toxic hydroxyl radicals and therefore chelation of iron could be a promising therapeutic approach in pathological states associated with oxidative stress. Salicylaldehyde isonicotinoyl hydrazone (SIH) is a strong intracellular iron chelator with well documented potential to protect against oxidative damage both in vitro and in vivo. Due to the short biological half-life of SIH and risk of toxicity due to iron depletion, boronate prochelator BSIH has been designed. BSIH cannot bind iron until it is activated by certain reactive oxygen species to active chelator SIH. The aim of this study was to examine the toxicity and cytoprotective potential of BSIH, SIH, and their decomposition products against hydrogen peroxide-induced injury of H9c2 cardiomyoblast cells. Using HPLC, we observed that salicylaldehyde was the main decomposition products of SIH and BSIH, although a small amount of salicylic acid was also detected. In the case of BSIH, the concentration of formed salicylaldehyde consistently exceeded that of SIH. Isoniazid and salicylic acid were not toxic nor did they provide any antioxidant protective effect in H9c2 cells. In contrast, salicylaldehyde was able to chelate intracellular iron and significantly preserve cellular viability and mitochondrial inner membrane potential induced by hydrogen peroxide. However it was consistently less effective than SIH. The inherent toxicities of salicylaldehyde and SIH were similar. Hence, although SIH - the active chelating agent formed following the BSIH activation - undergoes rapid hydrolysis, its principal decomposition product salicylaldehyde accounts markedly for both cytoprotective and toxic properties.
- 650 _2
- $a aldehydy $x farmakologie $x toxicita $7 D000447
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kyseliny boronové $x farmakologie $x toxicita $7 D001897
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 _2
- $a poločas $7 D006207
- 650 _2
- $a hydrazony $x farmakologie $x toxicita $7 D006835
- 650 _2
- $a peroxid vodíku $x toxicita $7 D006861
- 650 _2
- $a železo $x metabolismus $7 D007501
- 650 _2
- $a chelátory železa $x farmakologie $x toxicita $7 D007502
- 650 _2
- $a kyseliny isonikotinové $x farmakologie $x toxicita $7 D007539
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a myoblasty srdeční $x účinky léků $x metabolismus $7 D032386
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bureš, Jan $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Macháček, Miloslav $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Hašková, Pavlína $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Jirkovská, Anna $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Roh, Jaroslav $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Wang, Qin $u Department of Chemistry, Duke University, Durham, NC 22708, USA.
- 700 1_
- $a Franz, Katherine J $u Department of Chemistry, Duke University, Durham, NC 22708, USA.
- 700 1_
- $a Kovaříková, Petra $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Šimůnek, Tomáš $u Faculty of Pharmacy, Charles University in Prague, 500 05 Hradec Králové, Czech Republic. Electronic address: Tomas.Simunek@faf.cuni.cz.
- 773 0_
- $w MED00004533 $t Toxicology $x 1879-3185 $g Roč. 350-352, č. - (2016), s. 15-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27046792 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170829130646 $b ABA008
- 999 __
- $a ok $b bmc $g 1239768 $s 985000
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 350-352 $c - $d 15-24 $e 20160401 $i 1879-3185 $m Toxicology $n Toxicology $x MED00004533
- LZP __
- $a Pubmed-20170720